Related Experiment Video
Updated: Jan 4, 2026
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Early Liver Transplantation in Acute Alcoholic Hepatitis
Christine E Haugen1, Andrew M Cameron1
1Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Insights
Early liver transplantation for severe alcoholic hepatitis offers survival benefits for patients ineligible for standard transplant criteria. Short-term outcomes are favorable, suggesting this approach warrants further investigation for alcohol-related liver disease management.
Area of Science:
- Hepatology
- Transplantation Surgery
- Gastroenterology
Background:
- Alcohol-related liver disease (ALD) is the primary reason for liver transplants in the U.S.
- High mortality (70%) exists for acute alcoholic hepatitis patients unresponsive to treatment without transplant.
- Standard 6-month abstinence rules exclude many eligible ALD patients from transplantation.
Purpose of the Study:
- To evaluate the efficacy and outcomes of early liver transplantation (<6 months abstinence) for severe alcoholic hepatitis.
- To assess the survival benefit and relapse rates in patients undergoing early ALD liver transplantation.
Main Methods:
- Review of outcomes in patients receiving early liver transplantation for alcoholic hepatitis at select European and U.S. centers.
- Comparison of short-term outcomes and relapse rates with traditional transplant recipients.
Main Results:
- Early liver transplantation (<6 months abstinence) provides a significant survival advantage.
- Short-term outcomes for early transplant recipients are positive.
- Relapse rates in early transplant recipients are comparable to those who meet the 6-month abstinence criteria.
Conclusions:
- Early liver transplantation is a viable option for select patients with severe alcoholic hepatitis who do not meet standard criteria.
- Further research on long-term outcomes and optimal candidate selection is crucial for this expanding patient group.
Abstract:
Alcohol-related liver disease (ALD) is currently the leading indication for liver transplantation in the United States. Among patients with ALD, those with acute alcoholic hepatitis who do not respond to medical treatment have a 6-month mortality of 70% without transplantation. Despite the high mortality, the majority of patients will not be eligible for transplant, given that most centers follow the 6-month abstinence rule. A handful of centers in Europe and the United States perform early liver transplantation (< 6 months abstinence) in these patients, as it provides a substantial survival benefit. Short-term outcomes for these recipients are favorable, and relapse rates parallel those seen in alcoholic cirrhosis transplant recipients who have completed the 6-month wait period. Moving forward, studies examining long-term outcomes and candidate selection are necessary for this growing subset of liver transplant candidates.
More Related Videos
16:19Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019